Clinical trial
Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer
NCT02347852 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Physical Activity During Therapy With Regorafenib for Metastatic Colorectal Cancer
- Lead sponsor
- Bayer
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 20, 2015
- Completion date
- September 8, 2016
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.